 | Fulcrum Therapeutics, Inc. | |||
| NGM : FULC || Location: United States | ||||
$7.12-0.16 (-2.2%) |
0.17 M | 6.85 - 7.18 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 2.534 M |
| March 28, 2024 | 2.262 M |
| March 15, 2024 | 2.389 M |
| Feb. 29, 2024 | 3.196 M |
| Feb. 15, 2024 | 3.216 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.43 | -0.40 | 7.88% |
| 09/30/2023 | -0.44 | -0.39 | 12.10% |
| 06/30/2023 | -0.45 | -0.38 | 16.21% |
| 03/31/2023 | -0.46 | -0.41 | 11.75% |
| 12/31/2022 | -0.50 | -0.50 | -0.06% |
FULC Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 62.154M | Shares Float | 38.547M |
| Short Float | 2.534M | Market Cap | 450.89M |
| Institution ownership | 99.08% | Insider ownership | 1.377% |
| Earnings Date | 05/13/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -1.59 | Forward EPS | -1.71 |